Skip to main content
Premium Trial:

Request an Annual Quote

ABI Reverse Transcription Reagent Kits


Applied Biosystems has announced a number of reverse transcription reagent kits, which are optimized for use with its assays and real-time PCR instruments. The kits comprise a High Capacity RNA-to-cDNA Master Mix for first strand cDNA synthesis in high-throughput applications; a High Capacity RNA-to-cDNA Kit for first strand cDNA synthesis in low- to medium-throughput applications; a TaqMan RNA-to-CT 2-Step Kit and Power SYBR Green RNA-to-CT 2-Step Kit for screening a large number of targets from the same sample; as well as a TaqMan RNA-to-CT 1-Step Kit, to be released in April, and a Power SYBR Green RNA-to-CT 1-Step Kit for one-step workflows with reduced hands-on processing.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.